Centro Medico Prosalud
About Centro Medico Prosalud
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
EMD Serono Research & Development Institute, Inc.
4
Boehringer Ingelheim
3
EMD Serono
2
Eli Lilly and Company
2
Galapagos NV
2
Pfizer
2
Actelion
1
Hoffmann-La Roche
1
Idorsia Pharmaceuticals Ltd.
1
Clinical Trials at Centro Medico Prosalud
During the past decade, Centro Medico Prosalud conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 14 clinical trials were completed, i.e. on
average, 155.6% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 6 clinical trials were completed. i.e. 600%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Tocilizumab in Comparison to Etanercept in Participants With Rheumatoid Arthritis and Cardiovascular Disease Risk Factors
2011-08-02
2016-03-25
Completed
3,080
Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients
2011-12-01
2013-11-01
Completed
289
Efficacy, Pharmacokinetics, and Safety of BI 695500 in Patients With Rheumatoid Arthritis
2012-09-05
2016-10-12
Terminated
294
Dose-finding Study of GLPG0634 as add-on to Methotrexate in Active Rheumatoid Arthritis Participants (DARWIN1)
2013-07-17
2015-05-14
Completed
599
Efficacy and Safety of Atacicept in Systemic Lupus Erythematosus
2013-12-01
2016-09-01
Completed
306
Long-term Follow-up Study of GLPG0634 in Active Rheumatoid Arthritis Patients
2014-02-25
2023-01-19
Completed
739
Long-term Safety and Tolerability of Atacicept (Long-term Follow-Up of Participant Who Participated in ADDRESS II)
2014-07-29
2018-02-09
Terminated
253
Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
2014-03-14
2020-07-22
Completed
4,372
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Centro Medico Prosalud" #1 sponsor was "EMD Serono Research & Development Institute, Inc." with 4 trials, followed by "Boehringer Ingelheim" with 3 trials
sponsored, "EMD Serono" with 2 trials sponsored, "Eli Lilly and Company" with 2 trials sponsored and "Galapagos NV"
with 2 trials sponsored. Other sponsors include 0 different institutions and
companies that sponsored additional 9 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Centro Medico Prosalud"
#1 collaborator was "Merck KGaA, Darmstadt, Germany" with 4 trials as a collaborator, "Incyte Corporation" with 2 trials as a collaborator and "Gilead Sciences" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at Centro Medico Prosalud
According to Clinical.Site data, the most researched conditions in "Centro Medico Prosalud" are
"Systemic Lupus Erythematosus" (5 trials), "Arthritis, Rheumatoid" (4 trials), "Rheumatoid Arthritis" (4 trials), "Lupus Erythematosus, Systemic" (2 trials) and "Biliary Tract Cancer" (1 trials). Many other conditions were trialed in "Centro Medico Prosalud" in a lesser frequency.
Clinical Trials Intervention Types at Centro Medico Prosalud
Most popular intervention types in "Centro Medico Prosalud" are "Drug" (18 trials) and "Biological" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (8 trials), "Atacicept 150 mg" (2 trials), "BI 695501" (2 trials), "Baricitinib" (2 trials) and "Adalimumab with methotrexate" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Centro Medico Prosalud
The vast majority of trials in "Centro Medico Prosalud" are
18 trials for "All" genders.
Clinical Trials Status at Centro Medico Prosalud
Currently, there are NaN active trials in "Centro Medico Prosalud".
undefined are not yet recruiting,
1 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 13 completed trials in Centro Medico Prosalud,
undefined suspended trials,
and 4 terminated clinical trials to date.
Out of the total trials that were conducted in Centro Medico Prosalud, 0 "Phase 1"
clinical trials were conducted, 9 "Phase 2" clinical
trials and 7 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 3 trials, and there were
also 0 trials that are defined as “Not Applicable".